Session Information
Date: Tuesday, November 10, 2026
Session Type: Poster Session C
Session Time: 10:30AM-12:30PM
Background/Purpose: Axial spondyloarthritis (axSpA) is frequently accompanied by peripheral musculoskeletal (MSK) and extra-musculoskeletal (non-MSK) manifestations that influence prognosis and treatment. However, longitudinal data on their prevalence and short-term incidence in Latin America are scarce. ESPALDA is the first PANLAR-supported registry designed to characterize axSpA across the region. Objectives: To describe baseline prevalence and one-year incidence of MSK and non-MSK manifestations in axSpA patients from ESPALDA, and to explore factors associated with their development.
Methods: ESPALDA is a multicenter Latin American axSpA registry including referral centers from Argentina, Colombia, Ecuador, Mexico, Peru, Uruguay, Paraguay, Costa Rica, Honduras, and the Dominican Republic. Baseline prevalence was assessed in 741 patients. Incidence analyses were performed in 165 patients with complete one-year follow-up. MSK manifestations included peripheral arthritis and enthesitis; non-MSK manifestations included uveitis, inflammatory bowel disease (IBD), and psoriasis. Incidence rates were expressed as cases per 100 patient-years (PY) with 95% confidence intervals. Exploratory multivariable analyses were adjusted for sex, HLA-B27 status, and imaging findings.
Results: At baseline, peripheral arthritis was present in 22.2% and enthesitis in 29.7%. Non-MSK manifestations included uveitis in 23.1%, IBD in 5.1%, and psoriasis in 12.0%. In the one-year cohort, incidence of any MSK manifestation was 18.9 per 100 PY (95% CI 13.2-25.7), including 11.6 per 100 PY (95% CI 7.1-17.8) for peripheral arthritis and 12.8 per 100 PY (95% CI 8.0-19.4) for enthesitis. Incidence of any non-MSK manifestation was 7.3 per 100 PY (95% CI 3.8-12.4). Uveitis was the most frequent incident non-MSK event, with 4.1 per 100 PY (95% CI 1.9-7.8), followed by psoriasis (1.6 per 100 PY; 95% CI 0.4-4.2) and IBD (1.1 per 100 PY; 95% CI 0.2-3.6). Higher baseline ASDAS showed a trend toward incident MSK manifestations, but no robust independent predictors were identified. Sex, HLA-B27 positivity, and inflammatory imaging findings were not independently associated with incident MSK or non-MSK manifestations.
Conclusion: In this large PANLAR-supported Latin American axSpA registry, MSK and non-MSK manifestations were frequent at baseline and new events occurred during the first year. MSK manifestations were more common than non-MSK events, while uveitis was the leading incident extra-musculoskeletal manifestation. These findings support longitudinal assessment of peripheral and extra-musculoskeletal domains in axSpA and provide region-specific data to guide clinical monitoring and future research in Latin America.
To cite this abstract in AMA style:
Garcia Salinas R, CASASOLA J, Sommerfleck F, Guaracha Basañez G, Londono J, Gamboa-Cardenas R, Fernández-Ávila D, Vila D, Mestanza-Peralta M, Then J, Dufau E, BERMUDEZ P, Macias Oviedo L, Duran-Barragan S, Valdez Donelli F, Barcia M, Medina G, CASALLA L, Castillo Ortiz A, Chinchay L, Caballero L, Benegas M, Medina Bornachera D, Vega Nava C, Melgarejo P, Gomez A, Ferreyra L, Candia Zuniga D, gil d, Rivera Teran V, Eguez Del Pozo M, Sanchez Prado E, Avellanal V, Brance M, Marin Zucaro N, Bautista-Molano W. Axial Spondyloarthritis beyond the Spine in Latin America: One-Year Manifestation Patterns from the ESPALDA-PANLAR Registry [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 9). https://acrabstracts.org/abstract/axial-spondyloarthritis-beyond-the-spine-in-latin-america-one-year-manifestation-patterns-from-the-espalda-panlar-registry/. Accessed .ACR Meeting Abstracts - https://acrabstracts.org/abstract/axial-spondyloarthritis-beyond-the-spine-in-latin-america-one-year-manifestation-patterns-from-the-espalda-panlar-registry/


